Scientific ReportsDiabetes mellitus (DM) is a growing global health challenge, particularly in low-resource settings where access to effective therapies remains limited. Dual inhibition of dipeptidyl peptidase IV (DPP-IV) and sodium–glucose co-transporter 2 (SGLT2) offers
M. K. Letuku +4 more
doaj +1 more source
Review of sitagliptin phosphate: a novel treatment for type 2 diabetes
Vascular Health and Risk Management, 2007 Baptist GallwitzDept. Medicine IV, Eberhard Karls University, Tuebingen, GermanyAbstract: Sitagliptin (Januvia®, Merck Pharmaceuticals) is a dipeptidyl-peptidase inhibitor (DPP-4 inhibitor) that has recently been approved for the therapy of type 2 ...
Baptist Gallwitz
doaj
Meat Proteins as Dipeptidyl Peptidase IV Inhibitors and Glucose Uptake Stimulating Peptides for the Management of a Type 2 Diabetes Mellitus In Silico Study. [PDF]
Nutrients, 2019 Kęska P, Stadnik J, Bąk O, Borowski P.
europepmc +1 more source
A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV Inhibitors. [PDF]
Front Immunol, 2019 Izumi K, Nishie W, Beniko M, Shimizu H.
europepmc +1 more source
Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study. [PDF]
J Clin Med, 2018 Kim YG +6 more
europepmc +1 more source
In silico screening for identification of pyrrolidine derivatives dipeptidyl peptidase-IV inhibitors using COMFA, CoMSIA, HQSAR and docking studies. [PDF]
In Silico Pharmacol, 2017 Sharma MC, Jain S, Sharma R.
europepmc +1 more source
Safety and Efficiency of Dipeptidyl Peptidase IV Inhibitors in Patients with Diabetic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]
Curr Ther Res Clin ExpTuersun A, Mohetaer M, Hou G, Cheng G.
europepmc +1 more source
Efficacy and Safety of the Utilization of Dipeptidyl Peptidase IV Inhibitors in Diabetic Patients with Chronic Kidney Disease: A Meta-Analysis of Randomized Clinical Trials. [PDF]
Diabetes Metab Syndr ObesMahzari MM +6 more
europepmc +1 more source
In vitro screening for protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors from selected Nigerian medicinal plants. [PDF]
J Intercult Ethnopharmacol, 2017 Saidu Y +5 more
europepmc +1 more source
Bullous pemphigoid associated with dipeptidyl peptidase IV inhibitors. A case report and review of literature. [PDF]
J Dermatol Case Rep, 2014 Attaway A +3 more
europepmc +1 more source